Table 1. Baseline Biochemical And Clinical Characteristics Of Patients According To Gender.
| Variable | Males, n = 419 (86%) | Females, n = 66 (14%) | Total 485 | p-value |
| Blood glucose (mmol/l)* | 8.44 ± 4.36 | 10.9 ± 5.37 | 8.67 ± 4.54 | 0.005 |
| Blood pressure (mmHg)* | ||||
| Systolic | 129 ± 22 | 128 ± 22 | 129 ± 22 | 0.71 |
| Diastolic | 81 ± 16 | 78 ± 13 | 80 ± 16 | 0.26 |
| HDL cholesterol (mmol/l)* | 0.95 ± 0.28 | 1.14 ± 0.35 | 0.98 ± 0.29 | < 0.0001 |
| Triglycerides (mmol/l)* | 2.57 ± 1.84 | 2.36 ± 1.67 | 2.54 ± 1.81 | 0.39 |
| Abdominal circumference (cm)* | 96.08 ± 12.87 | 96.88 ± 11.48 | 96.18 ± 12.69 | 0.66 |
| Metabolic syndrome (NCEP ATP III)** | 245 (59%) | 50 (76%) | 295 (61%) | 0.007 |
| Metabolic syndrome (IDF)** | 242 (58%) | 48 (73%) | 290 (60%) | 0.02 |
| BMI (≥ 30 kg/m2)** | 72 (17%) | 21 (32%) | 93 (19%) | 0.002 |
*Values expressed as mean ± standard deviation; **number of individuals (% total). Figures in bold show significance at the 5% level. NCEP ATP III: National Cholesterol Education Program ATP III, IDF: International Diabetes Federation, HDL: high-density lipoprotein, BMI: body mass index.